Strategic Capabilities Zipher specializes in Medical Affairs strategic consulting and MSL optimization, presenting opportunities to offer expanded advisory services, training programs, and scalable MSL performance solutions to mid-to-large pharma and biotech clients seeking to enhance medical affairs outcomes.

Executive Leadership With a leadership team boasting over 30 years of industry experience, Zipher can be positioned as a trusted partner for complex Med Affairs programs, enabling premium services such as program design, governance, and high-level advisory engagements to larger pharmaceutical companies.

Growth History Acquisition by Arsenal Capital Partners signals a growth trajectory and potential access to a broader portfolio of healthcare brands, creating cross-sell opportunities into Arsenal’s existing portfolio and related portfolio companies in medical affairs and services.

Financial Scope Current revenue range of one to ten million dollars indicates room for upsell into larger, multi-year engagements and medium-sized pharma projects, including end-to-end MSL optimization, medical information support, and field medical operations.

Tech & Delivery Utilizes a mix of standard productivity and web technologies (Smartsheet, WordPress, Google Cloud) suggesting room to offer technology-enabled solutions for program management, analytics dashboards, and scalable training platforms tailored to medical affairs teams.